Medical Care
Global Personalized Cancer Vaccines Market Research Report 2025
- Jul 08, 25
- ID: 348034
- Pages: 84
- Figures: 81
- Views: 2
The global market for Personalized Cancer Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Vaccines.
The Personalized Cancer Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cancer Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
Segment by Type
By Cancer Type
By Mechanism of Action Type
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Vaccines.
The Personalized Cancer Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cancer Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
Segment by Type
By Cancer Type
By Mechanism of Action Type
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Cancer Type
1.2.3 By Mechanism of Action Type
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2020-2031)
2.2 Global Personalized Cancer Vaccines Growth Trends by Region
2.2.1 Global Personalized Cancer Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Cancer Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Personalized Cancer Vaccines Market Dynamics
2.3.1 Personalized Cancer Vaccines Industry Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2020-2025)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2024
3.5 Global Key Players of Personalized Cancer Vaccines Head office and Area Served
3.6 Global Key Players of Personalized Cancer Vaccines, Product and Application
3.7 Global Key Players of Personalized Cancer Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2026-2031)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2020-2031)
6.2 North America Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Cancer Vaccines Market Size by Country (2020-2025)
6.4 North America Personalized Cancer Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2020-2031)
7.2 Europe Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Cancer Vaccines Market Size by Country (2020-2025)
7.4 Europe Personalized Cancer Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2020-2031)
9.2 Latin America Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Cancer Vaccines Market Size by Country (2020-2025)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Cancer Type
1.2.3 By Mechanism of Action Type
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2020-2031)
2.2 Global Personalized Cancer Vaccines Growth Trends by Region
2.2.1 Global Personalized Cancer Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Cancer Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Personalized Cancer Vaccines Market Dynamics
2.3.1 Personalized Cancer Vaccines Industry Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2020-2025)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2024
3.5 Global Key Players of Personalized Cancer Vaccines Head office and Area Served
3.6 Global Key Players of Personalized Cancer Vaccines, Product and Application
3.7 Global Key Players of Personalized Cancer Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2026-2031)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2020-2031)
6.2 North America Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Cancer Vaccines Market Size by Country (2020-2025)
6.4 North America Personalized Cancer Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2020-2031)
7.2 Europe Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Cancer Vaccines Market Size by Country (2020-2025)
7.4 Europe Personalized Cancer Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2020-2031)
9.2 Latin America Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Cancer Vaccines Market Size by Country (2020-2025)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2020-2025)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Cancer Type
Table 3. Key Players of By Mechanism of Action Type
Table 4. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Personalized Cancer Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Cancer Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Personalized Cancer Vaccines Market Share by Region (2020-2025)
Table 8. Global Personalized Cancer Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Personalized Cancer Vaccines Market Share by Region (2026-2031)
Table 10. Personalized Cancer Vaccines Market Trends
Table 11. Personalized Cancer Vaccines Market Drivers
Table 12. Personalized Cancer Vaccines Market Challenges
Table 13. Personalized Cancer Vaccines Market Restraints
Table 14. Global Personalized Cancer Vaccines Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Personalized Cancer Vaccines Market Share by Players (2020-2025)
Table 16. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2024)
Table 17. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Personalized Cancer Vaccines, Headquarters and Area Served
Table 20. Global Key Players of Personalized Cancer Vaccines, Product and Application
Table 21. Global Key Players of Personalized Cancer Vaccines, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Personalized Cancer Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Personalized Cancer Vaccines Revenue Market Share by Type (2020-2025)
Table 25. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Personalized Cancer Vaccines Revenue Market Share by Type (2026-2031)
Table 27. Global Personalized Cancer Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Personalized Cancer Vaccines Revenue Market Share by Application (2020-2025)
Table 29. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Application (2026-2031)
Table 31. North America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Personalized Cancer Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 46. Advaxis Inc Company Details
Table 47. Advaxis Inc Business Overview
Table 48. Advaxis Inc Personalized Cancer Vaccines Product
Table 49. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 50. Advaxis Inc Recent Development
Table 51. Personalis Company Details
Table 52. Personalis Business Overview
Table 53. Personalis Personalized Cancer Vaccines Product
Table 54. Personalis Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 55. Personalis Recent Development
Table 56. Hoffmann-La Roche Ltd Company Details
Table 57. Hoffmann-La Roche Ltd Business Overview
Table 58. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product
Table 59. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 60. Hoffmann-La Roche Ltd Recent Development
Table 61. BioNtech Company Details
Table 62. BioNtech Business Overview
Table 63. BioNtech Personalized Cancer Vaccines Product
Table 64. BioNtech Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 65. BioNtech Recent Development
Table 66. Celldex Company Details
Table 67. Celldex Business Overview
Table 68. Celldex Personalized Cancer Vaccines Product
Table 69. Celldex Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 70. Celldex Recent Development
Table 71. CureVac AG Company Details
Table 72. CureVac AG Business Overview
Table 73. CureVac AG Personalized Cancer Vaccines Product
Table 74. CureVac AG Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 75. CureVac AG Recent Development
Table 76. Genetech Company Details
Table 77. Genetech Business Overview
Table 78. Genetech Personalized Cancer Vaccines Product
Table 79. Genetech Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 80. Genetech Recent Development
Table 81. Genocea Company Details
Table 82. Genocea Business Overview
Table 83. Genocea Personalized Cancer Vaccines Product
Table 84. Genocea Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 85. Genocea Recent Development
Table 86. Gritstone Oncology Company Details
Table 87. Gritstone Oncology Business Overview
Table 88. Gritstone Oncology Personalized Cancer Vaccines Product
Table 89. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 90. Gritstone Oncology Recent Development
Table 91. ISA Pharmaceuticals Company Details
Table 92. ISA Pharmaceuticals Business Overview
Table 93. ISA Pharmaceuticals Personalized Cancer Vaccines Product
Table 94. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 95. ISA Pharmaceuticals Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Personalized Cancer Vaccines Product
Table 99. Merck Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Moderna Therapeutics Company Details
Table 102. Moderna Therapeutics Business Overview
Table 103. Moderna Therapeutics Personalized Cancer Vaccines Product
Table 104. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 105. Moderna Therapeutics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Personalized Cancer Vaccines Picture
Figure 2. Global Personalized Cancer Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Cancer Vaccines Market Share by Type: 2024 VS 2031
Figure 4. By Cancer Type Features
Figure 5. By Mechanism of Action Type Features
Figure 6. Global Personalized Cancer Vaccines Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Personalized Cancer Vaccines Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Homecare Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Personalized Cancer Vaccines Report Years Considered
Figure 13. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Personalized Cancer Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Personalized Cancer Vaccines Market Share by Region: 2024 VS 2031
Figure 16. Global Personalized Cancer Vaccines Market Share by Players in 2024
Figure 17. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2024
Figure 19. North America Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 21. United States Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 25. Germany Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2020-2031)
Figure 33. China Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 41. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 45. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 49. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 50. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 51. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 52. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 53. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 54. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 55. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 56. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 57. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 59. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Cancer Type
Table 3. Key Players of By Mechanism of Action Type
Table 4. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Personalized Cancer Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Cancer Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Personalized Cancer Vaccines Market Share by Region (2020-2025)
Table 8. Global Personalized Cancer Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Personalized Cancer Vaccines Market Share by Region (2026-2031)
Table 10. Personalized Cancer Vaccines Market Trends
Table 11. Personalized Cancer Vaccines Market Drivers
Table 12. Personalized Cancer Vaccines Market Challenges
Table 13. Personalized Cancer Vaccines Market Restraints
Table 14. Global Personalized Cancer Vaccines Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Personalized Cancer Vaccines Market Share by Players (2020-2025)
Table 16. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2024)
Table 17. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Personalized Cancer Vaccines, Headquarters and Area Served
Table 20. Global Key Players of Personalized Cancer Vaccines, Product and Application
Table 21. Global Key Players of Personalized Cancer Vaccines, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Personalized Cancer Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Personalized Cancer Vaccines Revenue Market Share by Type (2020-2025)
Table 25. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Personalized Cancer Vaccines Revenue Market Share by Type (2026-2031)
Table 27. Global Personalized Cancer Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Personalized Cancer Vaccines Revenue Market Share by Application (2020-2025)
Table 29. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Application (2026-2031)
Table 31. North America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Personalized Cancer Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 46. Advaxis Inc Company Details
Table 47. Advaxis Inc Business Overview
Table 48. Advaxis Inc Personalized Cancer Vaccines Product
Table 49. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 50. Advaxis Inc Recent Development
Table 51. Personalis Company Details
Table 52. Personalis Business Overview
Table 53. Personalis Personalized Cancer Vaccines Product
Table 54. Personalis Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 55. Personalis Recent Development
Table 56. Hoffmann-La Roche Ltd Company Details
Table 57. Hoffmann-La Roche Ltd Business Overview
Table 58. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product
Table 59. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 60. Hoffmann-La Roche Ltd Recent Development
Table 61. BioNtech Company Details
Table 62. BioNtech Business Overview
Table 63. BioNtech Personalized Cancer Vaccines Product
Table 64. BioNtech Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 65. BioNtech Recent Development
Table 66. Celldex Company Details
Table 67. Celldex Business Overview
Table 68. Celldex Personalized Cancer Vaccines Product
Table 69. Celldex Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 70. Celldex Recent Development
Table 71. CureVac AG Company Details
Table 72. CureVac AG Business Overview
Table 73. CureVac AG Personalized Cancer Vaccines Product
Table 74. CureVac AG Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 75. CureVac AG Recent Development
Table 76. Genetech Company Details
Table 77. Genetech Business Overview
Table 78. Genetech Personalized Cancer Vaccines Product
Table 79. Genetech Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 80. Genetech Recent Development
Table 81. Genocea Company Details
Table 82. Genocea Business Overview
Table 83. Genocea Personalized Cancer Vaccines Product
Table 84. Genocea Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 85. Genocea Recent Development
Table 86. Gritstone Oncology Company Details
Table 87. Gritstone Oncology Business Overview
Table 88. Gritstone Oncology Personalized Cancer Vaccines Product
Table 89. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 90. Gritstone Oncology Recent Development
Table 91. ISA Pharmaceuticals Company Details
Table 92. ISA Pharmaceuticals Business Overview
Table 93. ISA Pharmaceuticals Personalized Cancer Vaccines Product
Table 94. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 95. ISA Pharmaceuticals Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Personalized Cancer Vaccines Product
Table 99. Merck Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Moderna Therapeutics Company Details
Table 102. Moderna Therapeutics Business Overview
Table 103. Moderna Therapeutics Personalized Cancer Vaccines Product
Table 104. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2020-2025) & (US$ Million)
Table 105. Moderna Therapeutics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Personalized Cancer Vaccines Picture
Figure 2. Global Personalized Cancer Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Cancer Vaccines Market Share by Type: 2024 VS 2031
Figure 4. By Cancer Type Features
Figure 5. By Mechanism of Action Type Features
Figure 6. Global Personalized Cancer Vaccines Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Personalized Cancer Vaccines Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Homecare Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Personalized Cancer Vaccines Report Years Considered
Figure 13. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Personalized Cancer Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Personalized Cancer Vaccines Market Share by Region: 2024 VS 2031
Figure 16. Global Personalized Cancer Vaccines Market Share by Players in 2024
Figure 17. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2024
Figure 19. North America Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 21. United States Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 25. Germany Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2020-2031)
Figure 33. China Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 41. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2020-2031)
Figure 45. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Personalized Cancer Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 49. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 50. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 51. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 52. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 53. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 54. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 55. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 56. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 57. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 59. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232